Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Ibuprofen for Cognitive Problems in Cancer
NCT03186638Phase 2Completed
- Sponsor
- University of Rochester Cancer Center NCORP Research Base
- Start
- May 2017
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ibuprofen in chemotherapy-induced cognitive impairment (CICI), sponsored by University of Rochester Cancer Center NCORP Research Base. Started May 2017; status: completed.
02
Drugs
ibuprofen
03
Conditions
chemotherapy-induced cognitive impairment (CICI)
Beyond the preview
Go deeper on NCT03186638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03186638.